Yangde Chen

Yangde Chen Email and Phone Number

Co-Founder, CTO and COO @ MLAB Biosciences
United States
Yangde Chen's Location
United States, United States
Yangde Chen's Contact Details
About Yangde Chen

In-depth knowledge and expertise in therapeutic antibody discovery, engineering, and developability assessment.Skilled in leading and managing internal cross-functional research projects and external collaborations.Experienced in performing scientific and technical due diligence of external opportunities.Veteran in managing teams and talent development to achieve persistent high level of productivity.Excellent oral and written communication skills.

Yangde Chen's Current Company Details
MLAB Biosciences

Mlab Biosciences

View
Co-Founder, CTO and COO
United States
Website:
mlabbiosciences.com
Employees:
10
Yangde Chen Work Experience Details
  • Mlab Biosciences
    Co-Founder, Cto And Coo
    Mlab Biosciences
    United States
    View
  • Mlab Biosciences
    Co-Founder, Cto/Coo
    Mlab Biosciences Nov 2022 - Present
    Lead a team in discovering, characterizing, engineering, and optimizing novel therapeutic antibodies, including bispecific and antibody fusion proteins, for patients with serious musculoskeletal diseases. Collaborate with the management team and other stakeholders to implement business strategies. Oversee daily business operations and administration.
    View
  • Abio-X
    Entrepreneur In Residence
    Abio-X Sep 2021 - Oct 2022
    Waltham, Massachusetts, Us
    Originated ideas for the therapeutic pipeline and conducted pilot studies. Assisted in recruiting and assembling the core scientific team.
    View
  • Oncusp Therapeutics
    Biologics Adviser
    Oncusp Therapeutics May 2021 - Sep 2021
    New York, New York, Us
    Provided experience-based consulting around biologics pipeline development, including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and recombinant proteins. Conducted in-depth due diligence using the latest scientific knowledge and competitive intelligence for potential in-licensing assets and made sound recommendations.Proposed discovery strategies for homegrown biologics program.
    View
  • Klus Pharma
    Vp, Innovative Biologics
    Klus Pharma Apr 2019 - Apr 2021
    Cranbury, Nj - New Jersey, Us
    Played an essential role in initiating new projects and developing research strategies.Led team to discover therapeutic antibodies (hybridoma, phage display, yeast display) and engineer novel bispecific antibodies for immune-oncology therapies. Served as the committee member to evaluate external technologies and therapeutic assets of various biologic modalities for in-licensing or collaboration.
    View
  • Abpro
    Vp, Head Of Antibody Discovery
    Abpro Aug 2017 - Apr 2019
    Woburn, Massachusetts, Us
    Formulated and executed research strategies to build and advance early therapeutic pipeline. Led / mentored team to develop, characterize, engineer, and optimize novel therapeutic antibodies (including bispecific and multi-specific) for immune-oncology therapy.Managed external partnership research.
    View
  • Sanofi
    Director / Associate Director
    Sanofi Jan 2011 - Aug 2017
    Paris, France, Fr
    Led the antibody discovery group in US Biologics Research, responsible for the generation and characterization of therapeutic antibodies and new technology implementation.
    View
  • Sanofi
    Expatriate (Lead Research Investigator), China R&D
    Sanofi Jan 2009 - Dec 2010
    Paris, France, Fr
    Played a leading role in managing the external research collaborations and in expanding Sanofi’s China research capabilities.
    View
  • Sanofi
    Principal Research Investigator / Research Investigator / Scientist
    Sanofi Mar 1997 - Dec 2008
    Paris, France, Fr
    Held different positions / roles with increasing responsibility.Played a key role in establishing the phage display and hybridoma platforms in Sanofi-Aventis US for therapeutic antibody discovery.
    View

Yangde Chen Skills

Molecular Biology Antibodies Cell Biology Life Sciences Pharmaceutical Industry Monoclonal Antibodies Biotechnology Drug Discovery Biomarker Discovery Biologics R&d Drug Development Pharmacology Target Identification Validation Cell Culture Phage Display Biotherapeutics Lifesciences Microarray Project Management Biochemistry R

Yangde Chen Education Details

  • Rutgers, The State University Of New Jersey-New Brunswick
    Rutgers, The State University Of New Jersey-New Brunswick
    Molecular Biology
  • Institute Of Microbiology, Chinese Academy Of Sciences
    Institute Of Microbiology, Chinese Academy Of Sciences
    Microbiology
  • Huazhong Agricultural University
    Huazhong Agricultural University
    Plant Pathology

Frequently Asked Questions about Yangde Chen

What company does Yangde Chen work for?

Yangde Chen works for Mlab Biosciences

What is Yangde Chen's role at the current company?

Yangde Chen's current role is Co-Founder, CTO and COO.

What is Yangde Chen's email address?

Yangde Chen's email address is ya****@****hoo.com

What schools did Yangde Chen attend?

Yangde Chen attended Rutgers, The State University Of New Jersey-New Brunswick, Institute Of Microbiology, Chinese Academy Of Sciences, Huazhong Agricultural University.

What skills is Yangde Chen known for?

Yangde Chen has skills like Molecular Biology, Antibodies, Cell Biology, Life Sciences, Pharmaceutical Industry, Monoclonal Antibodies, Biotechnology, Drug Discovery, Biomarker Discovery, Biologics, R&d, Drug Development.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.